Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boostrix vs Decavac in Adults 65+
NCT00835237Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2009
- Primary completion
- Jul 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) in Tetanus, diphtheria, pertussis, sponsored by GSK. Started Feb 2009; status: completed.
02
Drugs
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)
03
Conditions
Tetanusdiphtheriapertussis
Beyond the preview
Go deeper on NCT00835237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00835237.